Key result
Single-nucleus RNA sequencing in HCM maps genotype-linked remodeling driving arrhythmia, fibrosis, and vascular dysfunction.
Observational (n=47)
Single-nucleus RNA sequencing reveals multicellular, genotype-associated remodeling programs in HCM, providing insights into the molecular mechanisms underlying arrhythmia, fibrosis, microvascular dysfunction, and heart failure progression.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“This was interesting, because cardiomyopathies are usually thought of as diseases of heart muscle cells only.”
“It has long been known that HCM patients with a known genetic cause tend to suffer more severe disease, yet the molecular mechanisms accounting for this have remained unknown. We show that these patients have a distinct pattern of gene activity in their hearts.”
“It was intriguing to see that the unbiased multiomics factor analysis revealed that so many different cell types contribute to the signatures that distinguish between patient groups and controls.”
Genotype-linked programs may enable precision risk stratification in HCM; leaves open therapeutic translation pending functional validation.
Hypertrophic cardiomyopathy (HCM) is marked by asymmetric cardiac wall thickening, hypercontractility, diastolic dysfunction, and fibrosis. Pathogenic sarcomere gene variants cause HCM, but comparable abnormalities occur in patients with unexplained disease, albeit with fewer adverse events. To investigate stage- and genotype-specific disease mechanisms, we performed single-nucleus RNA sequencing of cardiac tissues from 47 patients with HCM, spanning obstructive HCM with preserved systolic function and end-stage HCM, and compared them with nonfailing donor and dilated cardiomyopathy hearts. We identified transcriptional programs associated with cardiomyocyte hypertrophy, fibrosis, and vascular remodeling. Pathogenic variant–positive early-stage HCM samples showed reduced cardiomyocyte abundance and expansion of a proarrhythmogenic cardiomyocyte state. We identified proline-rich 16 ( PRR16 ) as a cardiomyocyte growth–associated gene in HCM and validated its increased expression by RNA in situ hybridization and in a human induced pluripotent stem cell–derived cardiomyocyte HCM model. In HCM samples, fibroblast compositional shifts were associated with profibrotic activation and adverse extracellular matrix remodeling, accompanied by reduced collagen IV ( COL4A1/COL4A2 ) expression and ultrastructural basement membrane abnormalities. HCM samples also exhibited extensive vascular alterations, including shifts in endothelial cell subpopulations, reduced pericyte abundance suggestive of microvascular dysfunction, and increased lymphangiogenic vascular endothelial growth factor C signaling. Unsupervised and supervised machine learning approaches distinguished HCM from dilated cardiomyopathy and accurately predicted genotype status in early-stage HCM from cell type–resolved transcriptional profiles, revealing widespread genotype-driven remodeling. Together, our findings uncover multicellular, genotype-associated remodeling programs in HCM, providing insight into mechanisms underlying arrhythmia, fibrosis, microvascular dysfunction, and heart failure progression.
No takes yet. Share an insight, caveat, or question.
Adami et al. (2026) conducted an observational in Hypertrophic cardiomyopathy (n=47). Hypertrophic cardiomyopathy and pathogenic sarcomere gene variants vs. Nonfailing donor and dilated cardiomyopathy hearts was evaluated on Transcriptional programs associated with cardiomyocyte hypertrophy, fibrosis, and vascular remodeling. Single-nucleus RNA sequencing of cardiac tissues from 47 HCM patients identified multicellular, genotype-associated remodeling programs underlying arrhythmia, fibrosis, and microvascular dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: